Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Catalyzed Reaction of Cellulose and Lignin with Methyltrimethoxysilane-FT-IR, 13C NMR and 29Si NMR Studies.

Siuda J, Perdoch W, Mazela B, Zborowska M.

Materials (Basel). 2019 Jun 23;12(12). pii: E2006. doi: 10.3390/ma12122006.

2.

Corrigendum to "Cognitive impairment and BDNF serum levels" [Polish J. Neurol. Neurosurg. 51 (2017) 24-32].

Siuda J, Patalong-Ogiewa M, Żmuda W, Targosz-Gajniak M, Niewiadomska E, Matuszek I, Jędrzejowska-Szypułka H, Rudzińska-Bar M.

Neurol Neurochir Pol. 2017 Nov - Dec;51(6):537. doi: 10.1016/j.pjnns.2017.07.004. Epub 2017 Jul 14. No abstract available.

PMID:
28818513
3.

Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzinska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W.

Brain. 2017 Jun 1;140(6):e33. doi: 10.1093/brain/awx077. No abstract available.

4.

Cognitive impairment and BDNF serum levels.

Siuda J, Patalong-Ogiewa M, Żmuda W, Targosz-Gajniak M, Niewiadomska E, Matuszek I, Jędrzejowska-Szypułka H, Lewin-Kowalik J, Rudzińska-Bar M.

Neurol Neurochir Pol. 2017 Jan - Feb;51(1):24-32. doi: 10.1016/j.pjnns.2016.10.001. Epub 2016 Oct 21. Erratum in: Neurol Neurochir Pol. 2017 Nov - Dec;51(6):537. [Lewin-Kowalik, Joanna] added.

PMID:
28341039
5.

A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.

Carrasquillo MM, Allen M, Burgess JD, Wang X, Strickland SL, Aryal S, Siuda J, Kachadoorian ML, Medway C, Younkin CS, Nair A, Wang C, Chanana P, Serie D, Nguyen T, Lincoln S, Malphrus KG, Morgan K, Golde TE, Price ND, White CC, De Jager PL, Bennett DA, Asmann YW, Crook JE, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2017 Jun;13(6):663-673. doi: 10.1016/j.jalz.2016.10.005. Epub 2016 Dec 8.

6.

Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.

Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzińska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W.

Brain. 2017 Jan;140(1):98-117. doi: 10.1093/brain/aww261. Epub 2016 Nov 2. Erratum in: Brain. 2017 Jun 1;140(6):e37.

7.

Genetics of Parkinson's disease: a review of SNCA and LRRK2.

Konno T, Siuda J, Wszolek ZK.

Wiad Lek. 2016;69(3 Pt 1):328-32. Review.

PMID:
27486710
8.

Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.

Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, Payami H.

Hum Mol Genet. 2016 Sep 1;25(17):3849-3862. doi: 10.1093/hmg/ddw206. Epub 2016 Jul 11.

9.

Late-onset Alzheimer disease risk variants mark brain regulatory loci.

Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD, Wang C, Serie D, Wang X, Siuda J, Zou F, Chai HS, Younkin C, Crook J, Medway C, Nguyen T, Ma L, Malphrus K, Lincoln S, Petersen RC, Graff-Radford NR, Asmann YW, Dickson DW, Younkin SG, Ertekin-Taner N.

Neurol Genet. 2015 Jul 23;1(2):e15. doi: 10.1212/NXG.0000000000000012. eCollection 2015 Aug.

10.

Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.

Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbé C, Lorenzo-Betancor O, Moussaud-Lamodière EL, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Puschmann A, Nishioka K, Funayama M, Hattori N, Parisi JE, Petersen RC, Graff-Radford NR, Boeve BF, Springer W, Wszolek ZK, Dickson DW, Ross OA.

Neurology. 2015 Dec 8;85(23):2016-25. doi: 10.1212/WNL.0000000000002170. Epub 2015 Nov 11.

11.

Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.

Labbé C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorová I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA.

Neurology. 2015 Nov 10;85(19):1680-6. doi: 10.1212/WNL.0000000000001946. Epub 2015 Sep 2. Erratum in: Neurology. 2015 Nov 10;85(19):1728.

12.

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.

Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza AI, Labbe C, Walton RL, Strongosky AJ, van Gerpen JA, Uitti RJ, McLean PJ, Springer W, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, McCarthy A, Lynch T, Puschmann A, Rektorova I, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Ferman TJ, Boeve BF, Petersen RC, Parisi JE, Graff-Radford NR, Dickson DW, Wszolek ZK, Ross OA.

Eur J Neurol. 2015 Sep;22(9):1323-5. doi: 10.1111/ene.12770.

13.

(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation.

Fiesel FC, Ando M, Hudec R, Hill AR, Castanedes-Casey M, Caulfield TR, Moussaud-Lamodière EL, Stankowski JN, Bauer PO, Lorenzo-Betancor O, Ferrer I, Arbelo JM, Siuda J, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Dickson DW, Springer W.

EMBO Rep. 2015 Sep;16(9):1114-30. doi: 10.15252/embr.201540514. Epub 2015 Jul 10.

14.

Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus.

Labbé C, Ogaki K, Lorenzo-Betancor O, Carrasquillo MM, Heckman MG, McCarthy A, Soto-Ortolaza AI, Walton RL, Lynch T, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Dickson DW, Uitti RJ, Wszolek ZK, Ross OA.

PLoS One. 2015 Jun 19;10(6):e0128586. doi: 10.1371/journal.pone.0128586. eCollection 2015.

15.

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.

Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM.

Parkinsonism Relat Disord. 2015 Jul;21(7):675-82. doi: 10.1016/j.parkreldis.2015.04.029. Epub 2015 May 1. Review.

PMID:
25952959
16.

Early-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional study.

Siuda J, Jasinska-Myga B, Boczarska-Jedynak M, Opala G, Fiesel FC, Moussaud-Lamodière EL, Scarffe LA, Dawson VL, Ross OA, Springer W, Dawson TM, Wszolek ZK.

Parkinsonism Relat Disord. 2014 Nov;20(11):1274-8. doi: 10.1016/j.parkreldis.2014.08.019. Epub 2014 Sep 2.

17.

Parkinsonian syndrome in familial frontotemporal dementia.

Siuda J, Fujioka S, Wszolek ZK.

Parkinsonism Relat Disord. 2014 Sep;20(9):957-64. doi: 10.1016/j.parkreldis.2014.06.004. Epub 2014 Jun 13. Review.

18.

ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.

Siuda J, Lewicka T, Bujak M, Opala G, Golenia A, Slowik A, van Blitterswijk M, Baker M, Ertekin-Taner N, Wszolek ZK, Rademakers R.

Eur Neurol. 2014;72(1-2):64-71. doi: 10.1159/000362267. Epub 2014 May 24.

19.

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.

Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB, Aasly JO, Barcikowska M, Siuda J, Wszolek ZK, Ross OA, Carrasquillo M, Dickson DW, Graff-Radford N, Petersen RC, Ertekin-Taner N, Morgan K, Bu G, Younkin SG.

Mol Neurodegener. 2014 Mar 10;9:11. doi: 10.1186/1750-1326-9-11.

20.

Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.

Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G.

J Neurol Sci. 2013 Dec 15;335(1-2):58-63. doi: 10.1016/j.jns.2013.08.023. Epub 2013 Aug 27.

PMID:
24035276
21.

From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.

Siuda J, Gorzkowska A, Patalong-Ogiewa M, Krzystanek E, Czech E, Wiechuła B, Garczorz W, Danch A, Jasińska-Myga B, Opala G.

Neurol Neurochir Pol. 2009 Jul-Aug;43(4):321-9.

PMID:
19742390
22.

Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.

Targosz-Gajniak M, Siuda J, Ochudło S, Opala G.

J Neurol Sci. 2009 Aug 15;283(1-2):79-82. doi: 10.1016/j.jns.2009.02.314. Epub 2009 Mar 6.

PMID:
19268974
23.

Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.

Krzystanek E, Krzystanek M, Opala G, Trzeciak HI, Siuda J, Małecki A.

J Neural Transm (Vienna). 2007;114(8):1033-9. Epub 2007 Apr 20.

PMID:
17447002
24.

Vascular risk factors and intensity of cognitive dysfunction in MCI.

Siuda J, Gorzkowska A, Opala G, Ochudło S.

J Neurol Sci. 2007 Jun 15;257(1-2):202-5. Epub 2007 Mar 1.

PMID:
17335850
25.

[Melkersson-Rosenthal syndrome as a rare cause of recurrent facial nerve palsy].

Opala G, Krzystanek E, Siuda J, Pilch-Kowalczyk J.

Neurol Neurochir Pol. 2005 Jul-Aug;39(4):335-8. Polish.

PMID:
16096940
26.

[Inferior frontal region hypoperfusion in Parkinson disease with dementia].

Ochudło S, Opala G, Jasińska-Myga B, Siuda J, Nowak S.

Neurol Neurochir Pol. 2003;37 Suppl 5:133-44. Polish.

PMID:
15098340
27.

[Parkinsonism in chronic occupational metallic mercury intoxication].

Miller K, Ochudło S, Opala G, Smolicha W, Siuda J.

Neurol Neurochir Pol. 2003;37 Suppl 5:31-8. Polish.

PMID:
15098329
28.
30.

Synthesis and anti-cancer activity of 2-alkylaminomethyl-5-(E)-alkylidene cyclopentanone hydrochlorides.

Chen H, Ji Z, Wong LK, Siuda JF, Narayanan VL.

Bioorg Med Chem. 1994 Oct;2(10):1091-7.

PMID:
7773626
31.
33.

Chloroperoxidase mediated halogenation of phenols.

Wannstedt C, Rotella D, Siuda JF.

Bull Environ Contam Toxicol. 1990 Feb;44(2):282-7. No abstract available.

PMID:
2322670
34.

Evaluation of the side arm of (naphthylvinyl)pyridinium inhibitors of choline acetyltransferase.

DeBernardis JF, Gifford P, Rizk M, Ertel R, Abraham DJ, Siuda JF.

J Med Chem. 1988 Jan;31(1):117-21.

PMID:
3336013
36.

Halohydrocarbon synthesis by bromoperoxidase.

Theiler R, Cook JC, Hager LP, Siuda JF.

Science. 1978 Dec 8;202(4372):1094-6.

PMID:
17777960
37.
38.

Inhibition of tyrosinase-catalyzed melanin formation by catechol phenyl sulfones.

Siuda JF, Habal A.

J Med Chem. 1974 Nov;17(11):1173-7. No abstract available.

PMID:
4213190
40.

Naturally occurring halogenated organic compounds.

Siuda JF, DeBernardis JF.

Lloydia. 1973 Jun;36(2):107-43. Review. No abstract available.

PMID:
4598148
41.

Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.

Siuda JF, Cihonski C, Sofia RD, Buckley JP.

J Pharm Sci. 1973 Feb;62(2):331-2. No abstract available.

PMID:
4686418
42.

A simple and inexpensive method for the visual detection of sub-microgram amounts of halogenated substances present in gas chromatographic effluents.

Siuda JF, DeBernardis JF, Cavestri RC.

J Chromatogr. 1973 Jan 17;75(2):298-303. No abstract available.

PMID:
4701543
43.

New compounds: carbamate derivatives of mafenide (homosulfanilamide).

Siuda JF, Cihonski CD.

J Pharm Sci. 1972 Nov;61(11):1856-7. No abstract available.

PMID:
4652670
44.

[Distribution of doses in the pelvis in the treatment of carcinoma of the cervix. Calculation of doses from radium applicators at selected points in the pelvis].

Szymczyk W, Siuda J, Medvey W, Polak B, Polok B.

Pol Przegl Radiol Med Nukl. 1971 Jul-Aug;35(4):475-80. Polish. No abstract available.

PMID:
5114270
45.

o,o'-Disubstituted phenylcyclopropylamines.

Burger A, Siuda JF.

J Med Chem. 1969 Mar;12(2):317-20. No abstract available.

PMID:
5783609
46.

[Esophageal dose estimations utilizing the thermoluminescence method in rotation radiotherapy].

Szymczyk W, Siuda J, Kujawska J, Skolyszewski J.

Pol Przegl Radiol Med Nukl. 1969;33(6):821-5. Polish. No abstract available.

PMID:
5380756
47.

[Thermoluminescence dosimeter].

Szymczyk W, Siuda J, Drejak Z.

Pol Przegl Radiol Med Nukl. 1969;33(6):813-20. Polish. No abstract available.

PMID:
5380755
48.

Sterically hindered derivatives of homosulfanilamide.

Burger A, Siuda JF.

Arzneimittelforschung. 1968 Sep;18(9):1220-1. No abstract available.

PMID:
4885375
49.

[Estimation of doses in rotation radiotherapy of cancer of the esophagus].

Szymczyk W, Siuda J, Drejak Z, Kujawska J.

Pol Przegl Radiol Med Nukl. 1968;32(2):265-72. Polish. No abstract available.

PMID:
5664476
50.

[Significance of verification of the X-ray beam centering in the rotation technic].

Szymczyk W, Siuda J, Drejak Z.

Pol Przegl Radiol Med Nukl. 1967 Nov-Dec;31(6):875-9. Polish. No abstract available.

PMID:
5582529

Supplemental Content

Support Center